A compromised developmental trajectory of the infant gut microbiome and metabolome in atopic eczema
Нарушенная траектория развития микробиома и метаболома кишечника у младенцев при атопической экземе
2020-10-06
SCID: 54.1/uheqbce3
Discuss with AI
allergen sensitizationatopic eczemabutyrate and propionate productioninfant gut microbiomeintegrated multi-omics
Figures from the paper
Abstract (AI)
Evidence is accumulating that the establishment of the gut microbiome in early life influences the development of atopic eczema. In this longitudinal study, we used integrated multi-omics analyses to infer functional mechanisms by which the microbiome modulates atopic eczema risk. We measured the functionality of the gut microbiome and metabolome of 63 infants between ages 3 weeks and 12 months with well-defined eczema cases and controls in a sub-cohort from the Growing Up in Singapore Toward healthy Outcomes (GUSTO) mother-offspring cohort. At 3 weeks, the microbiome and metabolome of allergen-sensitized atopic eczema infants were characterized by an enrichment of Escherichia coli and Klebsiella pneumoniae, associated with increased stool D-glucose concentration and increased gene expression of associated virulence factors. A delayed colonization by beneficial Bacteroides fragilis and subsequent delayed accumulation of butyrate and propionate producers after 3 months was also observed. Here, we describe an aberrant developmental trajectory of the gut microbiome and stool metabolome in allergen sensitized atopic eczema infants.The infographic describes an impaired developmental trajectory of the gut microbiome and metabolome in allergen-sensitized atopic eczema (AE) infants and infer its contribution in modulating allergy risk in the Singaporean mother-offspring GUSTO cohort. The key microbial signature of AE is characterized by (1) an enrichment of Escherichia coli and Klebsiella pneumoniae which are associated with accumulation of pre-glycolysis intermediates (D-glucose) via the trehalose metabolic pathway, increased gene expression of associated virulence factors (invasin, adhesin, flagellin and lipopolysaccharides) by utilizing ATP from oxidative phosphorylation and delayed production of butyrate and propionate, (2) depletion of Bacteroides fragilis which resulted in lower expression of immunostimulatory bacterial cell envelope structure and folate (vitamin B9) biosynthesis pathway, and (3) accompanied depletion of bacterial groups with the ability to derive butyrate and propionate through direct or indirect pathways which collectively resulted in reduced glycolysis, butyrate and propionate biosynthesis.
Key Findings
1
After three months, eczema infants showed delayed accumulation of bacteria producing the short-chain fatty acids butyrate and propionate.
2
Allergen-sensitized infants who developed atopic eczema showed an aberrant longitudinal developmental trajectory of gut microbiome and metabolome from 3 weeks to 12 months.
3
At three weeks, Escherichia coli and Klebsiella pneumoniae were enriched and associated with increased stool D-glucose and expression of virulence factors, including invasin, adhesin, flagellin, and lipopolysaccharides.
4
Bacteroides fragilis colonization was delayed in eczema infants, accompanied by reduced expression of immunostimulatory bacterial cell-envelope structures and folate-related functions.
5
The observed microbial and metabolic disruptions suggest mechanisms by which early-life gut development may modulate atopic eczema and allergy risk.
Research Object
The developmental trajectory of the gut microbiome and stool metabolome in allergen-sensitized infants with atopic eczema
Research Subject
Aberrant microbial colonization, metabolite accumulation, functional gene expression, and production of butyrate and propionate associated with atopic eczema risk
Publication Details
Publication Date
2020-10-06
Journal
Publisher
ISSN
Cited by
123
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest